Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Early Versus Late Initiation of Edaravone Dexborneol on Neural Function in Patients With Acute Ischemic Stroke-A Multicenter, Randomized, Double-blind, Placebo-controlled, Trial

NCT05885919 is registered in ClinicalTrials.gov with Xiangya Hospital of Central South University as lead sponsor.

NCT NCT05885919
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05885919 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Early Versus Late Initiation of Edaravone Dexborneol on Neural Function in Patients With Acute Ischemic Stroke-A Multicenter, Randomized, Double-blind, Placebo-controlled, Trial
Lead sponsor
Xiangya Hospital of Central South University
Phase
Phase 3
Overall status
Unknown status
Start date
July 1, 2023
Completion date
December 31, 2024
Enrollment
212 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

ischemic stroke, acute, treatment outcome